Log in to save to my catalogue

Proof-of-concept study evaluating humoral primary immunodeficiencies via CJ:KREC ratio and serum BAF...

Proof-of-concept study evaluating humoral primary immunodeficiencies via CJ:KREC ratio and serum BAF...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_90b350488c8b4fe68f2f7ec57f116a18

Proof-of-concept study evaluating humoral primary immunodeficiencies via CJ:KREC ratio and serum BAFF level

About this item

Full title

Proof-of-concept study evaluating humoral primary immunodeficiencies via CJ:KREC ratio and serum BAFF level

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2024-06, Vol.14 (1), p.14356-7, Article 14356

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Humoral primary immunodeficiencies are the most prevalent form of primary immunodeficiency (PID). Currently, there is no convenient method to quantify newly formed B cells. The aim of this proof-of-concept study was to quantitate the ratio of coding joints (CJs) to Kappa-deleting recombination excision circles (KRECs) and serum B cell activating fa...

Alternative Titles

Full title

Proof-of-concept study evaluating humoral primary immunodeficiencies via CJ:KREC ratio and serum BAFF level

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_90b350488c8b4fe68f2f7ec57f116a18

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_90b350488c8b4fe68f2f7ec57f116a18

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-024-64942-4

How to access this item